blood thinner Tagged Articles
Lesser expensive generic drugs soon available, but are they safe?
The patents for several of the best-selling prescription medications will be expiring over the next two years, paving the way for drug companies to manufacture and sell less expensive generic versions of the drugs. Among the medications that will likely
Tainted lots of heparin recalled
Certain lots of the blood thinner heparin are being recalled because testing revealed that the drug is contaminated with trace amounts of oversulfated chondroitin sulfate (OSCS). The recall includes seven lots of Heparin Sodium USP Active Pharmaceutical Ingredient (API) sold
India’s booming drug market raises questions about quality
Drugs are becoming a booming business in India and are expected to grow 13 percent this year alone to just over $24 billion. With tougher patent laws and a more mainstream focus in the global drug industry, India is slowly
Baxter faces numerous lawsuits over tainted heparin scandal
As many as 300 product-liability lawsuits may be filed in the Illinois state court against drug maker Baxter International Inc., by people injured by or families who lost loved ones to contaminated batches of the blood thinner heparin. Per a
FDA notifies public about changes to heparin potency
The blood thinner heparin will now include a new reference standard and test method that is used to determine the potency of the drug and detect impurities that may be present in it, according to a safety alert issued by
USP updates standards for heparin
A recent report in Huliq News documents efforts by the U.S. Pharmacopeial (USP) Convention to improve the safety of blood thinner heparin by revising its written and physical standards for the drug. The update comes at the request of the
Four lawsuits filed in contaminated heparin case
Four lawsuits were filed last month in Cook County, Illinois court against the makers of the blood thinner heparin, claiming the product the company manufactured was contaminated and caused patients to die.
China says tainted drug blame should fall on foreign suppliers
A Chinese senior health official says China has been unfairly labeled as a center for fake drug production and that blame should be placed instead on foreign companies who do business with unregistered firms against Chinese regulations. Bian Zhenijia, director
Surgeons hopeful about new alternatives to heparin
Surgeons are anticipating the approval of new blood thinners that could replace more conventional methods currently in use, according to the Ortho SuperSite, a resource for orthopedic surgeons and rheumatologists.
FDA clears Baxter in deaths following heparin injections
Baxter Healthcare Corp. has been cleared by the Food and Drug Administration (FDA) in the deaths of two patients at a Delaware hospital following an injection of the drug maker’s blood thinner heparin. The FDA attributed the two deaths, and
